-
-
-
-
-
-
-
Theravance Biopharma drug trial fails, company cuts costs 60%
-
-
-
-
-
-
-
Theravance Biopharma (TBPH) Tops Q2 EPS by 41c, provides guidance
-
-
-
-
-
-
-
Theravance Biopharma, Inc. Reports Record Fourth Quarter and Full Year 2024 Financial Results
-
-
-
-
-
-
-
Theravance Biopharma, Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Theravance Biopharma to Report Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024
-
-
-
-
-
-
-
Theravance Biopharma (TBPH) Misses Q1 EPS by 9c
-
-
-
-
-
-
-
Theravance Biopharma to Report Fourth Quarter and Full Year 2022 Financial Results on February 27, 2023
-
1,218,242 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

